“…no, SPAC timeline still pending, but we’ve closed Singapore’s round. NeoGenePay BioTech Inc. is formally filed, compliance side is clean. Yea, the FDA data sandbox is already integrated with Nero’s model—we’re cross-checking the genomic indicators with AI-predicted therapy reactions…”